BIOMAT Database Logo BIOMAT Database Logo

Modulation of fibroblast growth factor-2 receptor binding, signaling, and mitogenic activity by heparin-mimicking polysulfonated compounds. 1999

S Liekens, and D Leali, and J Neyts, and R Esnouf, and M Rusnati, and P Dell'Era, and P C Maudgal, and E De Clercq, and M Presta
Rega Institute for Medical Research, University Hospital, Katholieke Universiteit Leuven, Leuven, Belgium. Liekens@rega.kuleuven.ac.be

Basic fibroblast growth factor (FGF-2) interacts with high-affinity tyrosine-kinase fibroblast growth factor receptors (FGFRs) and low-affinity heparan sulfate proteoglycans (HSPGs) in target cells. Both interactions are required for FGF-2-mediated biological responses. Here we report the FGF-2 antagonist activity of novel synthetic sulfonic acid polymers with distinct chemical structures and molecular masses (MMs). PAMPS [poly(2-acrylamido-2-methyl-1-propanesulfonic acid)], (MM approximately 7,000-10,000), PAS [poly(anetholesulfonic acid)], (MM approximately 9,000-11,000), PSS [poly(4-styrenesulfonic acid)], (MM = 70,000), and poly(vinylsulfonic acid) (MM = 2,000), inhibited FGF-2 binding to HSPGs and FGFRs in fetal bovine aortic endothelial GM 7373 cells. They also abrogated the formation of the HSPG/FGF-2/FGFR ternary complex, as evidenced by their capacity to prevent FGF-2-mediated cell-cell attachment of FGFR-1-overexpressing, HSPG-deficient Chinese hamster ovary cells to wild-type HSPG-bearing cells. Direct interaction of the polysulfonates with FGF-2 was demonstrated by their ability to protect the growth factor from proteolytic cleavage. Accordingly, molecular modeling, based on the crystal structure of the interaction of FGF-2 with a heparin hexamer, showed the feasibility of docking PAMPS into the heparin-binding domain of FGF-2. In agreement with their FGF-2-binding capacity, PSS, PAS, and PAMPS inhibited FGF-2-induced cell proliferation in GM 7373 cells and murine brain microvascular endothelial cells. The antiproliferative activity of these compounds was associated with the abrogation of FGF-2-induced tyrosine phosphorylation of FGFR-1. Moreover, the polysulfonates PSS and PAS inhibited FGF-2-induced activation of mitogen-activated protein kinase-1/2, involved in FGF-2 signal transduction. In conclusion, sulfonic acid polymers bind FGF-2 by mimicking heparin interaction. These compounds may provide a tool to inhibit FGF-2-induced endothelial cell proliferation in angiogenesis and tumor growth.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011108 Polymers Compounds formed by the joining of smaller, usually repeating, units linked by covalent bonds. These compounds often form large macromolecules (e.g., BIOPOLYMERS; PLASTICS). Polymer
D002417 Cattle Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor. Beef Cow,Bos grunniens,Bos indicus,Bos indicus Cattle,Bos taurus,Cow,Cow, Domestic,Dairy Cow,Holstein Cow,Indicine Cattle,Taurine Cattle,Taurus Cattle,Yak,Zebu,Beef Cows,Bos indicus Cattles,Cattle, Bos indicus,Cattle, Indicine,Cattle, Taurine,Cattle, Taurus,Cattles, Bos indicus,Cattles, Indicine,Cattles, Taurine,Cattles, Taurus,Cow, Beef,Cow, Dairy,Cow, Holstein,Cows,Dairy Cows,Domestic Cow,Domestic Cows,Indicine Cattles,Taurine Cattles,Taurus Cattles,Yaks,Zebus
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003198 Computer Simulation Computer-based representation of physical systems and phenomena such as chemical processes. Computational Modeling,Computational Modelling,Computer Models,In silico Modeling,In silico Models,In silico Simulation,Models, Computer,Computerized Models,Computer Model,Computer Simulations,Computerized Model,In silico Model,Model, Computer,Model, Computerized,Model, In silico,Modeling, Computational,Modeling, In silico,Modelling, Computational,Simulation, Computer,Simulation, In silico,Simulations, Computer
D004727 Endothelium A layer of epithelium that lines the heart, blood vessels (ENDOTHELIUM, VASCULAR), lymph vessels (ENDOTHELIUM, LYMPHATIC), and the serous cavities of the body. Endotheliums
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001667 Binding, Competitive The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements. Competitive Binding

Related Publications

S Liekens, and D Leali, and J Neyts, and R Esnouf, and M Rusnati, and P Dell'Era, and P C Maudgal, and E De Clercq, and M Presta
Modulation of fibroblast growth factor-2 receptor binding, dimerization, signaling, and angiogenic activity by a synthetic heparin-mimicking polyanionic compound.
April 1997, The Journal of clinical investigation,
S Liekens, and D Leali, and J Neyts, and R Esnouf, and M Rusnati, and P Dell'Era, and P C Maudgal, and E De Clercq, and M Presta
Receptor binding and mitogenic properties of mouse fibroblast growth factor 3. Modulation of response by heparin.
October 1995, The Journal of biological chemistry,
S Liekens, and D Leali, and J Neyts, and R Esnouf, and M Rusnati, and P Dell'Era, and P C Maudgal, and E De Clercq, and M Presta
Modulation of mitogenic activity and cellular binding of basic fibroblast growth factor by basic proteins.
April 1989, Journal of cellular biochemistry,
S Liekens, and D Leali, and J Neyts, and R Esnouf, and M Rusnati, and P Dell'Era, and P C Maudgal, and E De Clercq, and M Presta
Heparin modulates the receptor-binding and mitogenic activity of hepatocyte growth factor on hepatocytes.
December 1993, Experimental cell research,
S Liekens, and D Leali, and J Neyts, and R Esnouf, and M Rusnati, and P Dell'Era, and P C Maudgal, and E De Clercq, and M Presta
Receptor- and heparin-binding domains of basic fibroblast growth factor.
April 1988, Proceedings of the National Academy of Sciences of the United States of America,
S Liekens, and D Leali, and J Neyts, and R Esnouf, and M Rusnati, and P Dell'Era, and P C Maudgal, and E De Clercq, and M Presta
Laminarin sulfate mimics the effects of heparin on smooth muscle cell proliferation and basic fibroblast growth factor-receptor binding and mitogenic activity.
September 1995, Journal of cellular physiology,
S Liekens, and D Leali, and J Neyts, and R Esnouf, and M Rusnati, and P Dell'Era, and P C Maudgal, and E De Clercq, and M Presta
Oligomerization reduces heparin affinity but enhances receptor binding of fibroblast growth factor 2.
January 2000, The Biochemical journal,
S Liekens, and D Leali, and J Neyts, and R Esnouf, and M Rusnati, and P Dell'Era, and P C Maudgal, and E De Clercq, and M Presta
Modulation of mitogenic activity of fibroblast growth factors by inorganic polyphosphate.
July 2003, The Journal of biological chemistry,
S Liekens, and D Leali, and J Neyts, and R Esnouf, and M Rusnati, and P Dell'Era, and P C Maudgal, and E De Clercq, and M Presta
Heparin modulates the mitogenic activity of fibroblast growth factor by inducing dimerization of its receptor. a 3D view by using NMR.
September 2013, Chembiochem : a European journal of chemical biology,
S Liekens, and D Leali, and J Neyts, and R Esnouf, and M Rusnati, and P Dell'Era, and P C Maudgal, and E De Clercq, and M Presta
Binding of heparin/heparan sulfate to fibroblast growth factor receptor 4.
May 2001, The Journal of biological chemistry,
Copied contents to your clipboard!